Related Experiment Videos
Abnormalities in offspring associated with prenatal marihuana exposure
Developmental Pharmacology and Therapeutics
|January 1, 1985
Summary
Maternal cannabis use during pregnancy may lead to adverse infant outcomes, including growth retardation and neurological issues. Further research is needed to confirm the teratogenic potential of cannabis products.
Area of Science:
- Perinatal medicine
- Developmental toxicology
- Neuroscience
Background:
- Prenatal exposure to substances can impact fetal development.
- Cannabis use during pregnancy is a growing public health concern.
- Existing studies suggest potential risks associated with cannabis consumption in pregnant individuals.
Observation:
- Five newborn infants exposed to consistent maternal marihuana use before and during gestation were studied.
- These infants exhibited specific health problems.
- Observed issues included intrauterine growth retardation, neurological deficits, and abnormal morphogenesis.
Findings:
- Infants exposed to marihuana in utero showed signs of developmental impairment.
- The observed symptoms align with potential teratogenic effects of cannabis.
- These clinical observations support previous experimental and epidemiological data.
Implications:
- Cannabis use during pregnancy may pose risks to fetal development and infant health.
- Findings highlight the need for increased awareness and counseling regarding cannabis use in pregnant populations.
- Further rigorous studies are essential to definitively establish the teratogenic potential of cannabis.